immunity News and Research

RSS

Depression leads to elevated inflammatory proteins in the human body: Study

To help solve this long standing chicken and egg conundrum, researchers led by Jesse Stewart, Ph.D., assistant professor of psychology at Indiana University-Purdue University Indianapolis asked two critical questions. Does depression lead to elevated inflammatory proteins in the human body? Or does an increase in these proteins lead to depression? They found that the answer to the first question appears to be "yes," and the answer to the second question may be "no" among healthy adults.

6 Oct 2009

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.

5 Oct 2009

Global retail market for probiotic foods and beverages shows 13 percent increase over 2007

Once relegated primarily to the domain of yogurt and high-fiber fare, the market for food and beverage products fortified with probiotics and prebiotics has taken off as digestive health emerged as one of the hottest topics in the food and beverage arena.

5 Oct 2009

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.

5 Oct 2009

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

Quest PharmaTech Inc. ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced that it has acquired a pipeline of late-stage immunotherapy product candidates from Paladin Labs Inc. ("Paladin").

3 Oct 2009

NK cells keep T cells in check: Study

Natural killer, or NK cells, are part of our innate immune system. A healthy body produces them to respond early during infection. They are activated and they kill cells infected with a given virus.

3 Oct 2009

DelSite's assests acquired by Nanotherapeutics

Nanotherapeutics, Inc., a privately held specialty biopharmaceutical company, announced today that it had acquired certain assets from DelSite (formerly Carrington Laboratories, Inc.) out of Chapter 7 bankruptcy proceedings in the U.S. Bankruptcy Court for the Northern District of Texas, Dallas Division.

3 Oct 2009

$7.2 million grant awarded to develop microbicide-releasing vaginal ring

The National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University a four-year, $7.2 million grant to develop a microbicide-releasing vaginal ring to prevent HIV transmission.

3 Oct 2009

Studies show vitamin D plays an important role in preventing respiratory infections

Several studies and articles published this year show that vitamin D plays an important role in the prevention of respiratory infections such as the cold and flu.

1 Oct 2009

Children and adolescents over five are at risk from malaria

Insecticide treated mosquito nets reduce the chances of developing life-threatening malaria in Africa, however recent research shows that older children are the least well protected by nets in the community. The research, published in the open access journal BMC Public Health, has found that parents and their young children were much more likely to have malaria nets than older children.

1 Oct 2009

Poll reveals that 43% of American adults undecided about getting the swine flu vaccine

According to a new Consumer Reports poll, 43 percent of American adults say they're on the fence about getting the swine flu vaccine and just 34 percent of those polled plan on getting the swine flu vaccine when it becomes available. Additionally, a mere 35 percent of parents say they'll definitely have their children vaccinated. The Centers for Disease Control and Prevention recommends that all children over the age of 6 months get the vaccine.

1 Oct 2009

The still elusive malaria vaccine

A deadly disease, malaria afflicts 350-500 million people worldwide each year and kills more than a million people. Transmitted by Anopheles mosquitoes, the disease occurs in more than 100 countries and territories, with at least 40 percent of the world's population at risk.

30 Sep 2009

Researchers find new ways to treat Myelodysplastic Syndrome

Van Andel Research Institute (VARI) researchers are one step closer to finding new ways to treat Myelodysplastic Syndrome (MDS), a bone marrow disease that strikes up to 15,000 people each year in the United States, and that sometimes results in acute myeloid leukemia.

30 Sep 2009

The Australian Institute of Policy and Science awards Dr Jake Baum for malaria research

Research aimed at developing drugs that stop malaria parasites from spreading throughout the body has seen Dr Jake Baum, from the Walter and Eliza Hall Institute, named a Young Tall Poppy by the Australian Institute of Policy and Science.

25 Sep 2009

Collaboration for the evaluation of peptide copolymer technology

Peptimmune, Inc., a privately held biotechnology company announced today that it has formed a research and development collaboration with the Walter Reed Army Institute of Research (WRAIR) and the Naval Medical Research Center (NMRC), Silver Spring, MD to evaluate the Company's proprietary DEEP(TM) peptide copolymer technology for the potential development of dengue vaccines and point-of-care diagnostics.

25 Sep 2009

Researchers study functional similarity between zebrafish and humans to fight infections

Since the human response to infection is highly complex, research to understand how people fight infection is facilitated by studying how similar processes occur in simpler organisms. Zebrafish are becoming an important model for human disease, since they are easily handled, maintained and manipulated and many fundamental processes between zebrafish and humans are conserved.

24 Sep 2009

Doctor from Dallas files civil case in the U.S. Supreme Court against BCBS

Dr. Dralves Edwards, a board-certified family physician in Dallas, today filed a civil case in the U.S. Supreme Court against Blue Cross Blue Shield of Texas, the contractor for Medicare.

24 Sep 2009

La Jolla Institute scientist Hilde Cheroutre earns the 2009 NIH Director's Pioneer Award

A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards -- the 2009 NIH Director's Pioneer Award. The prestigious prize carries with it funding for total costs of up to $4.7 million over five years, and is designed to support the work of exceptionally creative scientists, whose novel proposals offer the potential to make extraordinary contributions to human health.

24 Sep 2009

Rescuing immune system cells can reduce risk of prostate cancer

Immune therapies have been explored as a way to treat cancer after it develops. But a new study from the University of Michigan Comprehensive Cancer Center suggests that genetic risk of prostate cancer can be reduced by rescuing critical immune system cells.

24 Sep 2009

Antigen to block infection by genetically-diverse strains of HIV

Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.

22 Sep 2009

immunity News and Research

Depression leads to elevated inflammatory proteins in the human body: Study

CSL Behring - Canada Research Chair to develop therapies for treating bleeding and immune system disorders

Global retail market for probiotic foods and beverages shows 13 percent increase over 2007

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

NK cells keep T cells in check: Study

DelSite's assests acquired by Nanotherapeutics

$7.2 million grant awarded to develop microbicide-releasing vaginal ring

Studies show vitamin D plays an important role in preventing respiratory infections

Children and adolescents over five are at risk from malaria

Poll reveals that 43% of American adults undecided about getting the swine flu vaccine

The still elusive malaria vaccine

Researchers find new ways to treat Myelodysplastic Syndrome

The Australian Institute of Policy and Science awards Dr Jake Baum for malaria research

Collaboration for the evaluation of peptide copolymer technology

Researchers study functional similarity between zebrafish and humans to fight infections

Doctor from Dallas files civil case in the U.S. Supreme Court against BCBS

La Jolla Institute scientist Hilde Cheroutre earns the 2009 NIH Director's Pioneer Award

Rescuing immune system cells can reduce risk of prostate cancer

Antigen to block infection by genetically-diverse strains of HIV

Industry Focus eBook - Cell biology (5th edition) eBook

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News